Shopping Cart
Remove All
Your shopping cart is currently empty
YG1702, a potent inhibitor specific to ALDH18A1, suppresses the proliferation of MYCN-amplified neuroblastoma (NB) and reduces MYCN expression. This compound exhibits high-affinity physical interaction with ALDH18A1, which may influence its enzymatic activity [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | 8-10 weeks | 8-10 weeks | |
| 50 mg | Inquiry | 8-10 weeks | 8-10 weeks |
| Description | YG1702, a potent inhibitor specific to ALDH18A1, suppresses the proliferation of MYCN-amplified neuroblastoma (NB) and reduces MYCN expression. This compound exhibits high-affinity physical interaction with ALDH18A1, which may influence its enzymatic activity [1]. |
| In vivo | YG1702, administered intraperitoneally at a dosage of 45 mg/kg every three days for a total of three administrations, inhibited the growth of xenografts in tumor-bearing mice [1]. |
| Molecular Weight | 478.56 |
| Formula | C23H30N2O7S |
| Cas No. | 724737-08-0 |
| Smiles | O=C(OCCOC)C1=C(NC(=C(C(=O)OCCSC(C)C)C1C=2C=CC=CC2N(=O)=O)C)C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.